Mixed-Reality Radiation Planning Market Report 2026

Mixed-Reality Radiation Planning Market Overview

• Mixed-Reality Radiation Planning market size has reached to $1.75 billion in 2025 • Expected to grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 29.9% • Growth Driver: Rising Prevalence Of Cancer Fueling The Growth Of The Market Due To The Need For Interactive, Precise, And Patient-Specific Treatment Planning • Market Trend: AI-Powered Imaging Systems Elevate Precision In Radiation Planning • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Mixed-Reality Radiation Planning Market?

The mixed reality radiation planning market refers to the segment of healthcare technology that uses augmented, virtual, and mixed-reality tools to assist clinicians in visualizing tumors, surrounding anatomy, and radiation dose distributions during treatment planning. It integrates 3D holographic imaging, real-time simulation, and immersive collaboration to improve precision, workflow efficiency, and clinician training in radiation oncology. The main components of mixed-reality radiation planning systems are hardware, software, and services. Hardware includes head-mounted displays, visualization devices, and interaction tools that enable immersive three-dimensional visualization of patient anatomy and radiation plans. These systems utilize technologies such as virtual reality, mixed reality, and augmented reality, deployed through on-premises, cloud-based, and hybrid models, applied in oncology, radiology, surgery, medical training, and others, among end users including hospitals, cancer treatment centers, research institutes, and others.

What Is The Mixed-Reality Radiation Planning Market Growth Forecast?

The mixed-reality radiation planning market size is expected to see expoential growth in the next few years. It will grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to growing investment in mixed-reality healthcare solutions, increasing adoption of immersive planning tools, rising demand for high-precision radiation therapy, expanding use of real-time visualization technologies, increasing integration of ai with mixed-reality systems. Major trends in the forecast period include technology advancements in mixed-reality platforms, innovations in immersive treatment planning tools, developments in real-time imaging integration, research and development in vr/ar-based medical applications, advancements in motion-adaptive visualization systems.

Global Mixed-Reality Radiation Planning Market Segmentation

1) By Component: Hardware, Software, Services 2) By Technology: Virtual Reality (VR), Mixed Reality (MR), Augmented Reality (AR) 3) By Deployment Mode: On-Premises, Cloud-Based, Hybrid 4) By Application: Oncology, Radiology, Surgery, Medical Training, Others 5) By End-User: Hospitals, Cancer Treatment Centers, Research Institutes, Others Subsegments: 1) By Hardware: Head Mounted Displays, Tracking Sensors, Workstations, Input Devices, Projection Systems 2) By Software: Treatment Planning Software, Visualization And Rendering Software, Image Fusion And Registration Software, Motion Management Software, Dosimetry Analysis Software 3) By Services: Installation And Implementation Services, Training And Education Services, Maintenance And Support Services, Consulting And Advisory Services, Workflow Optimization Services

What Is The Driver Of The Mixed-Reality Radiation Planning Market?

The rising prevalence of cancer is expected to propel the growth of the mixed‑reality radiation planning market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells that can damage surrounding tissues and organs if not treated effectively. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. Mixed‑reality radiation planning helps manage cancer by providing an interactive, 3D visualization of patient anatomy and tumor location, enabling precise treatment planning. It improves patient outcomes by enhancing accuracy, reducing radiation exposure to healthy tissues, and supporting more effective therapy delivery. For instance, in October 2025, according to NHS Digital, a UK government organisation, there were 354,820 new cancer diagnoses recorded in England in 2023, averaging 972 diagnoses per day and representing an increase of 8,605 cases compared to 2022, with prostate cancer being the most commonly diagnosed cancer at 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Therefore, the rising prevalence of cancer is driving the growth of the mixed‑reality radiation planning market.

Key Players In The Global Mixed-Reality Radiation Planning Market

Major companies operating in the mixed-reality radiation planning market are Microsoft Corporation, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Varian Medical Systems, Elekta AB, Brainlab AG, Magic Leap Inc., Materialise NV, Canon Medical Systems Corporation, C‑RAD AB, Medivis Inc., Surgical Theater Inc., Koninklijke Philips N.V., ImmersiveTouch Inc., EchoPixel Inc., Hindsyt, Spectronic Medical AB, ViewRay Inc.

Global Mixed-Reality Radiation Planning Market Trends and Insights

Major companies operating in the mixed‑reality radiation planning market are focusing on developing advanced products, such as AI-powered CT and MR systems, to boost treatment precision, enhance clinical efficiency, and reduce operational costs and environmental impact. AI-powered CT and MR systems refer to advanced diagnostic platforms that use artificial intelligence to improve image clarity, accelerate workflow, and enable more accurate planning for treatments like radiation therapy. For instance, in September 2025, Royal Philips, a Netherlands-based health technology company, launched the Rembra RT, Areta RT CT platforms, and the helium-free BlueSeal RT 1.5T MR system. These systems are designed to set new standards in precision cancer care, featuring innovations like an AI-based detector for clearer tumor imaging and sustainable helium-free operation. They incorporate ultra-fast image processing and workflow efficiencies that help care teams work faster while providing reliable, long-term value through features like an extended service life guarantee.

What Are Latest Mergers And Acquisitions In The Mixed-Reality Radiation Planning Market?

In March 2024, apoQlar GmbH, a Germany‑based medical XR software company, partnered with Mayo Clinic to integrate extended reality (XR) technology into radiation therapy planning and patient care workflows. Through this collaboration, apoQlar GmbH and Mayo Clinic aim to enhance radiation planning accuracy, interdisciplinary treatment coordination, and patient engagement by leveraging immersive XR tools that visualise complex anatomical data in real time. Mayo Clinic is a US‑based private academic medical center focused on integrated healthcare, education, and research.

Regional Insights

North America was the largest region in mixed reality radiation planning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mixed-Reality Radiation Planning Market?

The mixed-reality radiation planning market consists of revenues earned by entities by providing services such as 3D visualization of patient anatomy, treatment plan simulation, real-time interactive radiation dose planning, clinician training and rehearsal, workflow optimization, and integration of mixed-reality tools. The market value includes the value of related goods sold by the solution provider or integrated within the planning tools. Only goods and services traded between entities or sold to end consumers are included. The mixed-reality radiation planning market consists of sales of mixed-reality headsets and devices, 3D visualization and simulation software, interactive treatment planning platforms, holographic imaging systems, and integrated hardware-software solutions. Values in this market are ‘factory gate’ values, reflecting the value of goods sold by the manufacturers or creators of these tools, whether to other entities or directly to end customers. The value of goods in this market includes related services sold by the creators of the tools.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mixed-Reality Radiation Planning Market Report 2026?

The mixed-reality radiation planning market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mixed-reality radiation planning industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.